'Omi-whatever': Variant Grip on Stocks Lasted Just Two Weeks




  • In Business
  • 2021-12-08 12:35:19Z
  • By Bloomberg
 

(Bloomberg) -- Less than two weeks after the spread of a new coronavirus variant sent ripples through global stock markets, it's almost as if omicron never happened.

Most Read from Bloomberg

  • The World's Relentless Demand for Chips Turns Deadly in Malaysia

  • Sand and Soldiers Mix as Troops Move In to Protect Cancun Tourists

  • Even in the Metaverse, Not All Identities Are Created Equal

  • The $300 Billion Plan to Bring Green Power to China's Megacities

  • Meet the New Climate Refugee in Town: Coyotes

Equities have quickly rebounded from their recent slump, with the S&P 500 index closing on Tuesday at its highest level since Nov. 24, the last trading day before scientists warned about a potentially more transmissible strain of the virus. In Europe, the benchmark Stoxx 600 has also nearly recovered losses triggered by the omicron variant scare.

European stocks and U.S. futures contracts briefly spiked on Wednesday after Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine neutralizes omicron. More data from South Africa suggesting symptoms are mild had already given a green light for fast-money "to pile back into the buy everything global recovery trade," Jeffrey Halley, a senior market analyst at Oanda, wrote in a note entitled "Omi-whatever."

News of the new variant initially had a dramatic effect, prompting the biggest one-day drop since February for the S&P 500 index and wiping more than a half-trillion euros in market value from the main European benchmark. Still, strategists remained largely sanguine and -- in the absence of alarming news about the new strain -- investors rushed to buy the dip, with Bank of America Corp. reporting that clients last week pumped the most money into stocks since 2017.

While epidemiologists are still cautious, preliminary evidence suggests that booster shots can offer protection, while there's little appetite for governments on either side of the Atlantic to impose the kind of strict lockdowns seen before vaccines were widely available.

To be sure, even if omicron's impact on markets proves short-lived, the slump seen in the past two weeks serves as a reminder that virus-induced volatility is not over yet. Prior to their brief spike, European stocks had fallen to a session low after a Financial Times report said U.K. Prime Minister Boris Johnson was set to announce fresh restrictions in England.

"The most striking feature to me is how the recovery time around these events continues to shorten," said Carl Dooley, head of European trading at Cowen. "It even surprises the bulls, and has been excruciating for the bears."

(Updates with effect of vaccines on omicron in third paragraph)

Most Read from Bloomberg Businessweek

  • From the Great Resignation to Lying Flat, Workers Are Opting Out

  • Return-to-Office Chaos Is the Best Thing to Happen to Consultants Since Y2K

  • The Fall of a Russian Cyberexecutive Who Went Against the Kremlin

  • Paige Bueckers, a College Athlete Who's Cashing In

  • The Meme Stock

©2021 Bloomberg L.P.

COMMENTS

More Related News

Bitcoin Hovers Near $38,000 as Markets Await Fed Decision
Bitcoin Hovers Near $38,000 as Markets Await Fed Decision

(Bloomberg) -- Most Read from BloombergStock Rebound Fails and Futures Plunge on Earnings: Markets WrapMark Zuckerberg's Stablecoin Ambitions Unravel With...

U.S. New-Home Sales Surge Past Estimates, Reach Nine-Month High
U.S. New-Home Sales Surge Past Estimates, Reach Nine-Month High

(Bloomberg) -- Sales of new U.S. homes rose in December to a nine-month high, indicating firmer demand at the end of 2021 despite high prices and still...

Analysis-Fed tightening a sign to get the
Analysis-Fed tightening a sign to get the 'heck out' of U.S. stocks

U.S. stock markets, after enjoying their best three-year run in more than two decades, may soon have to cede the top spot. With the Fed preparing to raise...

DeSantis fumes over FDA interference on monoclonal antibody treatments
DeSantis fumes over FDA interference on monoclonal antibody treatments

Gov. Ron DeSantis is blasting the Biden administration after the FDA revoked the use of two different monoclonal antibody treatments, forcing Florida to...

Glencore
Glencore's Viterra Buys Gavilon Grains Unit to Expand in U.S.

(Bloomberg) -- Glencore Plc's Viterra unit agreed to buy the grains business of Gavilon Group LLC from Marubeni Corp., giving the world's top commodity...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business